Skip to main content
SpringerLink
Log in
Book cover

Sjögren’s Syndrome pp 85–106Cite as

Oral Involvement

  • Chapter
  • First Online:

  • 1287 Accesses

Abstract

This chapter summarizes the orofacial involvement in Sjögren syndrome (SS). Oral manifestations of SS are mainly xerostomia and hyposalivation, autoimmune sialadenitis causing salivary gland swelling, and secondary manifestations such as dental caries, oral candidiasis, bacterial sialadenitis, oral malodour, and oral ulcers. These secondary manifestations are the first features of the disease to become ­evident in approximately half of the patients with primary SS, and their identification is important for early diagnosis. Furthermore, as most SS patients consider oral complications a major factor of quality of life deterioration [1], their treatment should be a priority.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Fox PC, Bowman SJ, Segal B, Vivino FB, Murukutla N, Choueiri K, et al. Oral involvement in primary Sjögren syndrome. J Am Dent Assoc. 2008;139:1592–601.

    PubMed  Google Scholar 

  2. Ghezzi EM, Lange LA, Ship JA. Determination of variation of stimulated salivary flow rates. J Dent Res. 2000;79:1874M.

    Article  Google Scholar 

  3. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res. 1992;71:1363.

    Article  PubMed  CAS  Google Scholar 

  4. Kohler PF, Winter ME. A quantitative test for xerostomia. The saxon test, an oral equivalent of the schirmer test. Arthritis Rheum. 2005;28:1128–32.

    Article  Google Scholar 

  5. Jorkjend L, Johansson A, Johansson AK, Bergenholtz A. Resting and stimulated whole salivary flow rates in Sjögren’s syndrome patients over time: a diagnostic aid for subsidized dental care? Acta Odontol Scand. 2004;62(5):264–8.

    Article  PubMed  Google Scholar 

  6. Moore PA, Guggenheimer J. Medication-induced hyposalivation: etiology, diagnosis, and treatment. Compend Contin Educ Dent. 2008;29(1):50–5.

    PubMed  Google Scholar 

  7. Turner MD, Ship JA. Dry mouth and its effects on the oral health of elderly people. J Am Dent Assoc. 2007;138(Suppl):15S–20.

    PubMed  Google Scholar 

  8. Thomson WM, Lawrence HP, Broadbent JM, Poulton R. The impact of xerostomia on oral-health-related quality of life among younger adults. Health Qual Life Outcomes. 2006;4:86.

    Article  PubMed  Google Scholar 

  9. Johansson AK, Johansson A, Unell L, Ekbäck G, Ordell S, Carlsson GE. A 15-yr longitudinal study of xerostomia in a Swedish population of 50-yr-old subjects. Eur J Oral Sci. 2009;117(1):13–9.

    Article  PubMed  Google Scholar 

  10. Meurman JH, Tarkkila L, Tiitinen A. The menopause and oral health. Maturitas. 2009;63(1):56–62. Epub 2009 Mar 25.

    Article  PubMed  Google Scholar 

  11. Baum BJ, Ship JA, Wu AJ. Salivary gland function and aging: a model for studying the interaction of aging and systemic disease. Crit Rev Oral Biol Med. 1992;4(1):53–64.

    PubMed  CAS  Google Scholar 

  12. Yamamoto K, Nagashima H, Yamachika S, Hoshiba D, Yamaguchi K, Yamada H, et al. The application of a night guard for sleep-related xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(3):e11–4. Epub 2008 Jul 7.

    Article  PubMed  Google Scholar 

  13. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164(12):1275–84.

    Article  PubMed  Google Scholar 

  14. Cho MA, Ko JY, Kim YK, Kho HS. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology. J Oral Rehabil. 2010;37(3):185–93.

    Article  PubMed  Google Scholar 

  15. Longman LP, Higham SM, Bucknall R, Kaye SB, Edgar WM, Field EA. Signs and symptoms in patients with salivary gland hypofunction. Postgrad Med J. 1997;73(856):93–7.

    Article  PubMed  CAS  Google Scholar 

  16. Flaitz CM. Parotitis as the initial sign of juvenile Sjögren’s syndrome. Pediatr Dent. 2001;23(2):140–2.

    PubMed  CAS  Google Scholar 

  17. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Wolff A. Sjögren’s syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. J Oral Pathol Med. 2005;34(1):1–6.

    Article  PubMed  CAS  Google Scholar 

  18. Mellgren SI, Göransson LG, Omdal R. Primary Sjögren’s syndrome associated neuropathy. Can J Neurol Sci. 2007;34(3):280–7.

    PubMed  Google Scholar 

  19. Haldorsen K, Moen K, Jacobsen H, Jonsson R, Brun JG. Exocrine function in primary Sjögren syndrome: natural course and prognostic factors. Ann Rheum Dis. 2008;67(7):949–54. Epub Oct 25, 2007.

    Article  PubMed  CAS  Google Scholar 

  20. Alliende C, Kwon YJ, Brito M, Molina C, Aguilera S, Pérez P, et al. Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome. Ann Rheum Dis. 2008;67(10):1480–7. Epub 2007 Nov 12.

    Article  PubMed  CAS  Google Scholar 

  21. Reina S, Orman B, Anaya JM, Sterin-Borda L, Borda E. Cholinoreceptor autoantibodies in Sjögren syndrome. J Dent Res. 2007;86(9):832–6.

    Article  PubMed  CAS  Google Scholar 

  22. Mathews SA, Kurien BT, Scofield RH. Oral manifestations of Sjögren’s syndrome. J Dent Res. 2008;87(4):308–18.

    Article  PubMed  CAS  Google Scholar 

  23. Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, et al. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand. 2005;63(5):284–93.

    Article  PubMed  CAS  Google Scholar 

  24. Hjelmervik TO, Jonsson R, Bolstad AI. The minor salivary gland proteome in Sjögren’s syndrome. Oral Dis. 2009;15(5):342–53. Epub Apr 2, 2009.

    Article  PubMed  CAS  Google Scholar 

  25. Silvestre FJ, Puente A, Bagán JV, Castell JV. Presence of fibronectin peptides in saliva of patients with Sjögren’s syndrome: a potential indicator of salivary gland destruction. Med Oral Patol Oral Cir Bucal. 2009;14(8):e365–70.

    PubMed  Google Scholar 

  26. Navazesh M. How can oral health care providers determine if patients have dry mouth? J Am Dent Assoc. 2003;134(5):613–8.

    PubMed  Google Scholar 

  27. Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology (Oxford). 2009;48(9):1077–82. Epub Jun 24, 2009.

    Article  Google Scholar 

  28. Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection. J Am Dent Assoc. 2008;139(3):291–9; quiz 358–9.

    PubMed  Google Scholar 

  29. Guobis Z, Baseviciene N, Paipaliene P, Niedzelskiene I, Januseviciūte G. Aspects of xerostomia prevalence and treatment among rheumatic inpatients. Medicina (Kaunas). 2008;44(12):960–8.

    Google Scholar 

  30. Seo DG, Kim J, Lee CY, Park SH. Diagnosis of Sjögren’s syndrome from a xerostomia case accompanied by multiple dental caries. Oper Dent. 2009;34(3):359–64.

    Article  PubMed  Google Scholar 

  31. Llena C, Forner L, Baca P. Anticariogenicity of casein phosphopeptide-amorphous calcium phosphate: a review of the literature. J Contemp Dent Pract. 2009;10(3):1–9.

    PubMed  Google Scholar 

  32. Singh ML, Papas AS. Long-term clinical observation of dental caries in salivary hypofunction patients using a supersaturated calcium-phosphate remineralizing rinse. J Clin Dent. 2009;20(3):87–92.

    PubMed  Google Scholar 

  33. Scardina GA, Ruggieri A, Messina P. Periodontal disease and Sjögren syndrome: a possible correlation? Angiology. 2010;61(3):289–93.

    Article  PubMed  Google Scholar 

  34. Mutlu S, Porter SR, Richards A, Scully C, Maddison P. Gingival and periodontal health in Sjogren’s syndrome and other connective tissue disorders. Clin Exp Rheumatol. 1993;11:95–6.

    PubMed  CAS  Google Scholar 

  35. Antoniazzi RP, Miranda LA, Zanatta FB, Islabão AG, Gustafsson A, Chiapinotto GA, et al. Periodontal conditions of individuals with Sjögren’s syndrome. J Periodontol. 2009;80(3):429–35.

    Article  PubMed  Google Scholar 

  36. Boutsi EA, Paikos S, Dafni UG, Moutsopoulos HM, Skopouli FN. Dental and periodontal status of Sjögren’s syndrome. J Clin Periodontol. 2000;27:231–5.

    Article  PubMed  CAS  Google Scholar 

  37. Schiødt M, Christensen LB, Petersen PE, Thorn JJ. Periodontal disease in primary Sjögren’s syndrome. Oral Dis. 2001;7(2):106–8.

    PubMed  Google Scholar 

  38. Gomes SG, Custódio W, Cury AA, Garcia RC. Effect of salivary flow rate on masticatory efficiency. Int J Prosthodont. 2009;22(2):168–72.

    PubMed  Google Scholar 

  39. Turner M, Jahangiri L, Ship JA. Hyposalivation, xerostomia and the complete denture: a systematic review. J Am Dent Assoc. 2008;139(2):146–50.

    PubMed  Google Scholar 

  40. Leung KC, McMillan AS, Cheung BP, Leung WK. Sjögren’s syndrome sufferers have increased oral yeast levels despite regular dental care. Oral Dis. 2008;14(2):163–73.

    Article  PubMed  CAS  Google Scholar 

  41. Radfar L, Shea Y, Fischer SH, Sankar V, Leakan RA, Baum BJ, et al. Fungal load and candidiasis in Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96(3):283–7.

    Article  PubMed  Google Scholar 

  42. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78:455–9.

    Article  PubMed  CAS  Google Scholar 

  43. Scully C, El-Kabir M, Samaranayake LP. Candida and oral candidosis. Crit Rev Oral Biol Med. 1994;5:124–58.

    Google Scholar 

  44. Torres SR, Peixoto CB, Caldas DM, Akiti T, Barreiros MG, de Uzeda M, et al. A prospective randomized trial to reduce oral Candida spp. colonization in patients with hyposalivation. Braz Oral Res. 2007;21(2):182–7.

    Article  PubMed  Google Scholar 

  45. Nagy K, Urban E, et al. Controlled study of lactoperoxidase gel on oral flora and saliva in irradiated patients with oral cancer. J Craniofac Surg. 2007;18:1157.

    Article  PubMed  Google Scholar 

  46. Lundström IM, Lindström FD. Subjective and clinical oral symptoms in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 1995;13(6):725–31.

    PubMed  Google Scholar 

  47. Bartunková J, Sedivá A, Vencovsky J, Tesar V. Primary Sjögren’s syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol. 1999;17:381–6.

    PubMed  Google Scholar 

  48. Khosroshahi A, Stone JH. IgG4-related systemic disease: overview of the clinical features. Curr Opin Rheumatol. 2011;23:57–66.

    Article  PubMed  CAS  Google Scholar 

  49. Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. Clinical and pathological differences between Mikulicz’s disease and Sjogren’s syndrome. Rheumatology. 2005;44:227–34.

    Article  PubMed  CAS  Google Scholar 

  50. Yamamoto M, Harada S, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.

    Article  PubMed  CAS  Google Scholar 

  51. Manoussakis MN. Sjogren’s Syndrome Orphanet encyclopedia. November 2001 http://www.orpha.net/data/patho/GB/uk-sjogren.pdf.

  52. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337–44.

    Article  PubMed  Google Scholar 

  53. Roh LJ, Huh J, Suh C. Primary non-Hodgkin’s lymphomas of the major salivary glands. J Surg Oncol. 2008;97:35–9.

    Article  PubMed  Google Scholar 

  54. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, The Members of the European Concerted Action on Sjögren’s Syndrome. Malignant lymphoma in primary Sjögren’s syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sjögren’s syndrome. Arthritis Rheum. 1999;42:1765–72.

    Article  PubMed  CAS  Google Scholar 

  55. Smedby KE et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029–38.

    Article  CAS  Google Scholar 

Key Websites (Accessed Dec 19, 2009)

Download references

Author information

Authors and Affiliations

  1. Division of Maxillofacial Diagnostic, Medical and Surgical Sciences, University College London (UCL) – Eastman Dental Institute, London, UK

    Crispian Scully

  2. First Department of Dermatology and Venereology, A. Syggros Hospital, School of Medicine, University of Athens, Athens, Greece

    Eleni A. Georgakopoulou

Authors
  1. Crispian Scully
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eleni A. Georgakopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Barcelona, Surgey, Hospital Clinic, Calle Villarroel, 170, Barcelona, 08036, Spain

    Manuel Ramos-Casals

  2. Massachusetts General Hospital, Boston, 02114, Massachusetts, USA

    John H. Stone

  3. National University of Athens, Athens, Greece

    Haralampos M. Moutsopoulos

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Scully, C., Georgakopoulou, E.A. (2011). Oral Involvement. In: Ramos-Casals, M., Stone, J., Moutsopoulos, H. (eds) Sjögren’s Syndrome. Springer, London. https://doi.org/10.1007/978-0-85729-947-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-947-5_6

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-946-8

  • Online ISBN: 978-0-85729-947-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation